Lumira-backed Cardiac Dimensions tops up funding to $28.5 mln
Cardiac Dimensions Inc has added US$8.5 million to a previously announced round of financing, bringing the round's total to US$28.5 million. The latest tranche was provided by U.S. venture capital firm Arboretum Ventures, which joins existing investors that include Canadian firm Lumira Capital and M.H. Carnegie & Co. Cardiac, a developer of minimally invasive treatments for heart failure and related cardiovascular conditions, said the funds will be used to expand commercial activity and capitalize on clinical trial results. Founded in 2001, the company is based in Kirkland, Washington.
8 October 2014•4 mins read
